Clinical Trial for Urinary Incontinence, Stress and Overweight and/or Obesity.

Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition

Urinary Incontinence, Stress, Overweight and/or Obesity

Sex

Female

Age

18+ years

Healthy participants

Visit ClinicalTrials.gov for more information

Eligibility criteria

Inclusion criteria

Adult women aged 18 years or older
Body mass index (BMI) of 27 kg/m² or greater
Have a diagnosis of stress urinary incontinence
Willing and able to comply with study procedures

Exclusion criteria

Have had urinary incontinence surgery
Have taken medications (prescribed or over-the counter) intended to promote weight loss within 90 days prior to randomization
Have recently received onabotulinumtoxin A (Botox) bladder injections or currently taking medications for urinary incontinence
History of acute or chronic pancreatitis
Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN-2)
Have diabetes or laboratory assessments indicative of diabetes
Have had a cardiovascular health condition within 90 days prior to randomization
Are breastfeeding, pregnant, parturition in the past 12 months, planning to become pregnant in the following 12 months, or of childbearing potential and not using adequate contraception

Study overview

The purpose of this study is to learn about the safety and effectiveness of berobenatide in adult women who have both stress urinary incontinence (SUI) and obesity or overweight.

Participants will be in the study for about 63 weeks

Join PfizerConnect

The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight

Who may participate

Eligibility criteria

Study overview

View locations for this study

Nearest Locations found

Join PfizerConnect

The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight

Who may participate

Eligibility criteria

Study overview

View locations for this study

Nearest Locations found

Are you a Healthcare Professional?